IR
Superintel
Overview
Markets
Watchlist
More
Avanir Pharmaceuticals Inc
CUSIP: 05348P951 | 4 institutional holders
Watch
Quarters
Q4 2014
Q3 2014
Q2 2014
Q1 2014
Q4 2013
All
Compare
Detailed
Historical
Funds
Options
Short Interest
13D/13G
Peers
Targeting
Trading Summary
Profile